Axogen, Inc. has grown revenue 19% a year over three years and 14% a year over five. Revenue growth, 3-year annual rate: +19% (Medical Devices median +12%). Revenue growth, 5-year rate: +14%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

AXGNAxogen, Inc.

Healthcare

$36.13+110% 1Y

$36.13

$15.5952 weeks$51.57

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +24% year on year, but operating margin narrowing (−5.9 points).

1 good, 1 to watch, 1 without data

Revenue trend+24% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +14% a year.

Margin direction−5.9 points operating

Trailing-twelve-month operating margin, -5.2% now against 0.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 87% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AXGN growing?

Axogen, Inc. has grown revenue 19% a year over three years and 14% a year over five.

+19%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +14%
Revenue growth, 5-year rate · +19% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›